Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B1132 TarafenacinSummary: M3 muscarinic receptor antagonist
- B1133 Tarafenacin D-tartrateSummary: Highly selective M3 muscarinic receptor antagonist
- B1028 Ciproxifan maleateSummary: Potent histamine H3 receptor antagonist
- B2254 SB269970 HClSummary: 5-HT7 receptor antagonist,potent and selective
- B2165 GW791343 HClSummary: P2X7 allosteric modulator
- B1200 PRX-08066Summary: 5-HT2BR antagonist
- B1459 ValdecoxibTarget: COXSummary: COX-2 inhibitor
- B1102 BrexpiprazoleSummary: 5-HT2A, α1B-, and α2C-adrenergic receptors antagonist
- B2262 AgomelatineSummary: MT1/MT2 / 5-HT2C agonist
- B1547 Cetirizine DiHClTarget: Histamine H1 ReceptorsSummary: H1 receptor inverse agonist